Assembly Biosciences, Inc.
ASMB
$30.82
$0.411.35%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 313.74% | 4.34% | 8.55% | 2.85% | 5.72% |
| Total Depreciation and Amortization | 0.00% | -3.03% | 0.00% | 3.13% | -61.90% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 63.21% | 306.51% | 196.92% | 354.82% | -50.34% |
| Change in Net Operating Assets | -192.90% | -20.87% | -17.02% | -64.72% | -88.76% |
| Cash from Operations | 3,598.03% | 0.73% | 2.01% | -27.64% | -100.55% |
| Capital Expenditure | -- | -- | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 417.31% | -746.15% | 231.85% | -61.90% | 92.53% |
| Cash from Investing | 416.95% | -746.32% | 232.76% | -61.87% | 92.53% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -97.32% | -- | -97.13% | -- | 84.89% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -97.32% | -- | -97.13% | -- | 84.89% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 263.08% | -115.92% | 29.19% | -1,267.31% | 245.15% |